Technology News and Research

RSS

FDA issues CRL for AZ-004 NDA application

Alexza Pharmaceuticals, Inc. announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA) for AZ-004 (Staccato loxapine), submitted as Adusuve Staccato (loxapine) inhalation aerosol, 5 mg and 10 mg.

11 Oct 2010

Researchers develop new approach to treat inflammatory bowel disease

Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.

11 Oct 2010

Progress in understanding mechanism behind photocontact allergy

What happens to sunscreens when they are exposed to sunlight? And how is the skin affected by the degradation products that form? This has been the subject of research at the University of Gothenburg and Chalmers University of Technology that will be presented at the upcoming dermatologist conference in Gothenburg.

11 Oct 2010

ImmunoGen enter collaboration agreement with Novartis to develop targeted anticancer therapeutics

ImmunoGen, Inc. announced today that it has entered into a collaboration agreement with Novartis to discover and develop targeted anticancer therapeutics using antibodies to several antigen targets to be named by Novartis.

11 Oct 2010

ESC pleased with European Health Award recognition for Chronic Disease Alliance

The European Society of Cardiology is delighted to see the European Health Award 2010 handed to the Chronic Disease Alliance at the 13th European Health Forum held in Gastein 6 - 9 October 2010.

11 Oct 2010

Doctors, med students face higher risks of suicide

News outlets report on workforce issues for doctors, including elevated suicide risk and hesitance to e-mail with patients.

11 Oct 2010

HHS awards Sanofi Pasteur 3-year, $56.94M egg supply contract for pandemic vaccine preparedness

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has been awarded a three-year contract for $56.94 million by the U.S. Department of Health and Human Services (HHS) to maintain flocks to enable manufacturing pandemic influenza vaccine at full capacity on a year-round basis.

11 Oct 2010

UH researchers receive grant to develop Blue Scale device to track heart failure

As more and more medical care is provided in the home, health specialists say it is critical for people to be able to monitor themselves and make informed judgments about their health. A group of researchers in the Abramson Center for the Future of Health at the University of Houston (UH) received a $250,000 pre-seed grant from the Texas Emerging Technology Fund (ETF) for a system that assesses cardiac function in the home and alerts the user to the need for intervention.

11 Oct 2010

Takeda, Envoy enter three-year research alliance to develop schizophrenia drug

Takeda Pharmaceutical Company Limited, a global pharmaceutical company, and Envoy Therapeutics Inc., a recently formed drug discovery company, today announced that they have formed a three-year research alliance aimed at discovering drugs for schizophrenia that will have greater efficacy and safety compared to current therapies.

11 Oct 2010

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

IntegenX, Inc. today announced that it has been awarded a new contract by the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to develop an Integrated Sample-to-Sequence (ISS) system for rapid detection and identification of genetically engineered bacteria and viruses, medically relevant bacteria and viruses, and emerging pathogens.

11 Oct 2010

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).

11 Oct 2010

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Integra LifeSciences Holdings Corporation announced today that it is featuring the Inforce Reinforcement Matrix at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Boston, Massachusetts.

8 Oct 2010

People involved in ATV crashes are more likely to die from serious trauma: Research

In research that may surprise off-road riding enthusiasts and safety experts, a Johns Hopkins team has found that crashes involving ATVs four-wheeled all-terrain vehicles — are significantly more dangerous than crashes involving two-wheeled off-road motorcycles, such as those used in extreme sports like Motocross.

8 Oct 2010

Experts meet on ESMO Congress to bring new hope to cancer patients

"A congress of records," is how Professor David J. Kerr, President of the European Society for Medical Oncology described the 35th ESMO Congress, at the opening press conference for the biggest medical oncology event in Europe. "We have had record numbers of submitted and accepted abstracts and are expecting a record number of attendees." The ESMO meeting brings together cancer specialists, patients, industry representatives and members of the media. The 35th ESMO Congress takes place at Fiera Milano City, in Milan, Italy, from 8 to 12 October 2010.

8 Oct 2010

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department's Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company's flagship StrataGraft living human skin substitute tissue.

8 Oct 2010

SRA International receives award of task order to continue support for TCGA

SRA International, Inc., a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced the award of a task order as a contractor to the National Institutes of Health to continue bioinformatics support of the Data Coordinating Center for The Cancer Genome Atlas.

8 Oct 2010

GE Healthcare announces successful completion of vendor neutral DI-r

GE Healthcare announced today the successful completion of a vendor neutral Digital Imaging Repository that connects hospitals and medical centers throughout Southwestern Ontario, Canada, enabling the sharing of patient health data across the region. For the first time in Ontario's history, 26 hospital organizations in the Erie St. Clair and South West Local Health Integration Networks are able to share filmless diagnostic image exams between their facilities.

8 Oct 2010

ABMS awarded HHS contract to align meaningful use of HIT, ABMS MOC program

The American Board of Medical Specialties announced today a contract from the U.S. Department of Health and Human Services to align the meaningful use of health information technology and the ABMS Maintenance of Certification program, which was created by ABMS and its 24 Member Boards to promote lifelong learning and self assessment for physician specialists. The contract was awarded by the HHS Office of the National Coordinator for HIT.

8 Oct 2010

Health-TIES consortium aims to accelerate innovation in healthcare

On Thursday 7 October, Europe's top regions in healthcare technology will launch the Health-TIES consortium that aims to accelerate innovation in healthcare. The consortium is backed by a three-year grant from the European Commission and is set up to strengthen the research potential of European regions through research-driven clusters of universities, research centres, enterprises and regional authorities.

8 Oct 2010

Study finds boosting mitochondria may delay onset of Parkinson's disease

In a study that sheds new light on the causes of Parkinson's disease, researchers report that brain cells in Parkinson's patients abandon their energy-producing machinery, the mitochondria. A shutdown in fuel can have devastating effects on brain cells, which consume roughly 20 percent of the body's energy despite making up only 2 percent of body weight.

8 Oct 2010

Technology News and Research

FDA issues CRL for AZ-004 NDA application

Researchers develop new approach to treat inflammatory bowel disease

Progress in understanding mechanism behind photocontact allergy

ImmunoGen enter collaboration agreement with Novartis to develop targeted anticancer therapeutics

ESC pleased with European Health Award recognition for Chronic Disease Alliance

Doctors, med students face higher risks of suicide

HHS awards Sanofi Pasteur 3-year, $56.94M egg supply contract for pandemic vaccine preparedness

UH researchers receive grant to develop Blue Scale device to track heart failure

Takeda, Envoy enter three-year research alliance to develop schizophrenia drug

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

People involved in ATV crashes are more likely to die from serious trauma: Research

Experts meet on ESMO Congress to bring new hope to cancer patients

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

SRA International receives award of task order to continue support for TCGA

GE Healthcare announces successful completion of vendor neutral DI-r

ABMS awarded HHS contract to align meaningful use of HIT, ABMS MOC program

Health-TIES consortium aims to accelerate innovation in healthcare

Study finds boosting mitochondria may delay onset of Parkinson's disease

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News